Status:
UNKNOWN
Treatment of Chemotherapy-related Hiccups With Baclofen
Lead Sponsor:
Second Affiliated Hospital of Nanchang University
Conditions:
Hiccup
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Hiccup is one of the common side effects of chemotherapy. Intractable hiccups seriously affect patients' rest and eating, reduce the quality of life, and increasingly attract the attention of oncologi...
Detailed Description
Hiccup is due to paroxysmal paralysis of the diaphragm, sudden inhalation of gas accompanied by rapid glottis closure and a short high-pitched sound, commonly known as "snoring", is one of the common ...
Eligibility Criteria
Inclusion
- Pathological diagnosis of malignant tumors;PS score 0 \~ 3 points;
- Hiccups occurred within 48 h after chemotherapy, lasting longer than 2 h.
Exclusion
- No serious heart, brain, lung, kidney and other diseases, no gastrointestinal bleeding, no serious obstacles to blood clotting;
- Blood routine and normal electrolyte of liver and kidney function before chemotherapy.
Key Trial Info
Start Date :
December 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03778281
Start Date
December 12 2018
End Date
December 20 2019
Last Update
December 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.